Provided by Tiger Trade Technology Pte. Ltd.

POINT BIOPHARMA GLOBAL INC

12.50
0.0000
Volume:- -
Turnover:41.13M
Market Cap:1.33B
PE:13.92
High:12.50
Open:12.50
Low:12.50
Close:12.50
52wk High:14.35
52wk Low:6.39
Shares:106.57M
Float Shares:70.03M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8979
EPS(LYR):1.04
ROE:26.33%
ROA:16.77%
PB:3.14
PE(LYR):12.03

Loading ...

Aug 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 30, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 21, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 09, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 09, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 04, 2021

Major Issues Report

8-K - Current report
Jun 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 01, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 01, 2021

Major Issues Report

8-K - Current report
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 03, 2021

Correspondence

CORRESP [Cover] - Correspondence